$247 Million is the total value of Skorpios Trust's 4 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AKRO | AKERO THERAPEUTICS INC | $125,180,178 | +69717.6% | 3,271,829 | 0.0% | 50.58% | -11.3% | |
| STOK | STOKE THERAPEUTICS INC | $120,315,863 | +90149.3% | 14,443,681 | 0.0% | 48.62% | +14.7% | |
| ATVI | ACTIVISION BLIZZARD INC | $1,848,744 | +111741.7% | 21,600 | 0.0% | 0.75% | +42.0% | |
| XBI | SPDR SER TRs&p biotech | $128,490 | +91678.6% | 1,686 | 0.0% | 0.05% | +15.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STOKE THERAPEUTICS INC | 8 | Q3 2023 | 99.8% |
| SPDR SER TR | 8 | Q3 2023 | 0.2% |
| AKERO THERAPEUTICS INC | 7 | Q2 2023 | 57.0% |
| ACTIVISION BLIZZARD INC | 7 | Q2 2023 | 0.7% |
| ORGANON & CO | 1 | Q4 2021 | 0.0% |
View Skorpios Trust's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Akero Therapeutics, Inc. | September 12, 2023 | ? | ? |
View Skorpios Trust's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-26 |
| 4 | 2024-04-18 |
| SC 13D/A | 2024-04-18 |
| 13F-HR | 2024-02-06 |
| 13F-HR | 2023-11-06 |
| SC 13G/A | 2023-09-12 |
| 13F-HR | 2023-08-03 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-07 |
| 4 | 2022-12-05 |
View Skorpios Trust's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.